Advertisement
Mayo Clinic Proceedings Home

Epidemiological Profile of Marfan Syndrome in a General Population: A National Database Study

      Abstract

      Objective

      To explore the current epidemiological profile of Marfan syndrome in a general population.

      Patients and Methods

      Patients who had received a diagnosis of Marfan syndrome were identified from the Taiwan National Health Insurance database records from January 1, 2000, through December 31, 2012 (average population size, 22,765,535). Cardiovascular events and interventions were identified by using the respective International Classification of Diseases codes.

      Results

      We identified 2329 patients (58% men) with Marfan syndrome. The overall prevalence was 10.2 (95% CI, 9.8-10.7) per 100,000 individuals, with peaks at the age of 15 to 19, 10 to 14, and 20 to 24 years. The minimal birth incidence of 23.3 (95% CI, 21.7-23.3) per 100,000 individuals was estimated in those aged 20 to 29 years. The average annual mortality was 0.23% (69 deaths), mostly owing to cardiac causes (including dissection and sudden death in 40 patients, 58%). Aortic dissection occurred in 226 patients (10%; 61% men) at a mean age of 36.6±10.7 years. The probability of freedom from dissection was 99%, 80%, and 66% at the age of 20, 40, and 50 years, respectively. Of the 69 deaths and 226 dissections during the follow-up period, more than half of the cases occurred before the age of 40 years. Cardiovascular intervention was performed in 360 patients, with early mortality being higher in the emergent operation group (8%) than in the elective group (0%).

      Conclusion

      From this national cohort study, the minimal birth incidence was 23.3 per 100,000 individuals, that is, possibly 1 patient with Marfan syndrome per 4286 people. Despite medical advances, aortic dissection still occurs in about one-tenth of the patients and carries a high mortality risk. Early diagnosis and timely medical interventions are warranted.

      Abbreviations and Acronyms:

      ACEI (angiotensin-converting enzyme inhibitor), NHI (National Health Insurance)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic and Personal

      Subscribe:

      Subscribe to Mayo Clinic Proceedings
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Murdoch J.L.
        • Walker B.A.
        • Halpern B.L.
        • Kuzma J.W.
        • McKusick V.A.
        Life expectancy and causes of death in the Marfan syndrome.
        N Engl J Med. 1972; 286: 804-808
        • von Kodolitsch Y.
        • Robinson P.N.
        Marfan syndrome: an update of genetics, medical and surgical management.
        Heart. 2007; 93: 755-760
        • Judge D.P.
        • Dietz H.C.
        Marfan's syndrome.
        Lancet. 2005; 366: 1965-1976
        • Pearson G.D.
        • Devereux R.
        • Loeys B.
        • et al.
        Report of the National Heart, Lung, and Blood Institute and National Marfan Foundation Working Group on research in Marfan syndrome and related disorders.
        Circulation. 2008; 118: 785-791
        • Li-Wan-Po A.
        • Loeys B.
        • Farndon P.
        • Latham D.
        • Bradley C.
        Preventing the aortic complications of Marfan syndrome: a case-example of translational genomic medicine.
        Br J Clin Pharmacol. 2011; 72: 6-17
        • Gray J.R.
        • Bridges A.B.
        • Faed M.J.
        • et al.
        Ascertainment and severity of Marfan syndrome in a Scottish population.
        J Med Genet. 1994; 31: 51-54
        • Pyeritz R.E.
        Marfan syndrome: 30 years of research equals 30 years of additional life expectancy.
        Heart. 2009; 95: 173-175
        • Silverman D.I.
        • Burton K.J.
        • Gray J.
        • et al.
        Life expectancy in the Marfan syndrome.
        Am J Cardiol. 1995; 75: 157-160
        • Wu M.H.
        • Chen H.C.
        • Wang J.K.
        • Chiu H.H.
        • Huang S.C.
        • Huang S.K.
        Population study of pediatric sudden death in Taiwan.
        J Pediatr. 2009; 155: 870-874
        • Jondeau G.
        • Detaint D.
        • Tubach F.
        • et al.
        Aortic event rate in the Marfan population: a cohort study.
        Circulation. 2012; 125: 226-232
        • Silverman D.I.
        • Gray J.
        • Roman M.J.
        • et al.
        Family history of severe cardiovascular disease in Marfan syndrome is associated with increased aortic diameter and decreased survival.
        J Am Coll Cardiol. 1995; 26: 1062-1067
        • Groenink M.
        • Lohuis T.A.
        • Tijssen J.E.
        • et al.
        Survival and complication free survival in Marfan's syndrome: implications of current guidelines.
        Heart. 1999; 82: 499-504
        • Gott V.L.
        • Greene P.S.
        • Alejo D.E.
        • et al.
        Replacement of the aortic root in patients with Marfan's syndrome.
        N Engl J Med. 1999; 340: 1307-1313
        • Gott V.L.
        • Cameron D.E.
        • Alejo D.E.
        • et al.
        Aortic root replacement in 271 Marfan patients: a 24-year experience.
        Ann Thorac Surg. 2002; 73: 438-443
        • Gersony D.R.
        • McClaughlin M.A.
        • Jin Z.
        • Gersony W.M.
        The effect of beta-blocker therapy on clinical outcome in patients with Marfan's syndrome: a meta-analysis.
        Int J Cardiol. 2007; 114: 303-308
        • Chiu H.H.
        • Wu M.H.
        • Wang J.K.
        • et al.
        Losartan added to β-blockade therapy for aortic root dilation in Marfan syndrome: a randomized, open-label pilot study.
        Mayo Clin Proc. 2013; 88: 271-276
        • Ahimastos A.A.
        • Aggarwal A.
        • D'Orsa K.M.
        • et al.
        Effect of perindopril on large artery stiffness and aortic root diameter in patients with Marfan syndrome: a randomized controlled trial.
        JAMA. 2007; 298: 1539-1547
        • Bentall H.
        • De Bono A.
        A technique for complete replacement of the ascending aorta.
        Thorax. 1968; 23: 338-339
        • David T.E.
        • Feindel C.M.
        An aortic valve-sparing operation for patients with aortic incompetence and aneurysm of the ascending aorta.
        J Thorac Cardiovasc Surg. 1992; 103: 617-621
        • Birks E.J.
        • Webb C.
        • Child A.
        • Radley-Smith R.
        • Yacoub M.H.
        Early and long-term results of a valve-sparing operation for Marfan syndrome.
        Circulation. 1999; 100: II29-II35
        • David T.E.
        • Armstrong S.
        • Maganti M.
        • Colman J.
        • Bradley T.J.
        Long-term results of aortic valve sparing operations in patients with Marfan syndrome.
        J Thorac Cardiovasc Surg. 2009; 138: 859-864
        • de Oliveira N.C.
        • David T.E.
        • Ivanov J.
        • et al.
        Results of surgery for aortic root aneurysm in patients with Marfan syndrome.
        J Thorac Cardiovasc Surg. 2003; 125: 789-796
        • Bernhardt A.M.
        • Treede H.
        • Rybczynski M.
        • et al.
        Comparison of aortic root replacement in patients with Marfan syndrome.
        Eur J Cardiothorac Surg. 2011; 40: 1052-1057
        • Tambeur L.
        • David T.E.
        • Unger M.
        • Armstrong S.
        • Ivanov J.
        • Webb G.
        Results of surgery for aortic root aneurysm in patients with the Marfan syndrome.
        Eur J Cardiothorac Surg. 2000; 17: 415-419
        • Yu H.Y.
        • Chen Y.S.
        • Huang S.C.
        • Wang S.S.
        • Lin F.Y.
        Late outcome of patients with aortic dissection: study of a national database.
        Eur J Cardiothorac Surg. 2004; 25: 683-690
        • Lepore V.
        • Jeppsson A.
        • Rådberg G.
        • Mantovani V.
        • Bugge M.
        Aortic surgery in patients with Marfan syndrome: long-term survival, morbidity and function.
        J Heart Valve Dis. 2001; 10: 25-30